DNA methylation profiles and biomarkers of oral squamous cell carcinoma

References

• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136:E359-86; PMID:25220842; http://dx.doi.org/10.1002/ijc.29210
   PubMed Web of Science ®Google Scholar
• Department of Health, Executive Yuan, R.O.C.(TAIWAN). 2009 Statistics of Causes of Death. Taipei, Taiwan, 2010.
   Google Scholar
• Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45:309-16; PMID:18804401; http://dx.doi.org/10.1016/j.oraloncology.2008.06.002
   PubMed Web of Science ®Google Scholar
• Lo WL, Kao SY, Chi LY, Wong YK, Chang RC. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. Journal of Oral and Maxillofacial Surgery 2003; 61:751-8; PMID:12856245; http://dx.doi.org/10.1016/S0278-2391(03)00149-6
   PubMed Web of Science ®Google Scholar
• Richards D. Patient delay in reporting oral cancer is poorly understood. Evid Based Dent 2007; 8:21; PMID:17380180; http://dx.doi.org/10.1038/sj.ebd.6400472
   PubMedGoogle Scholar
• Chen CL, Chi CW, Chang KW, Liu TY. Safrole-like DNA adducts in oral tissue from oral cancer patients with a betel quid chewing history. Carcinogenesis 1999; 20:2331-4; PMID:10590228; http://dx.doi.org/10.1093/carcin/20.12.2331
   PubMed Web of Science ®Google Scholar
• Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24:450-3; PMID:8600280; http://dx.doi.org/10.1111/j.1600-0714.1995.tb01132.x
   PubMed Web of Science ®Google Scholar
• Jones PA. DNA methylation and cancer. Oncogene 2002; 21:5358-60; PMID:12154398; http://dx.doi.org/10.1038/sj.onc.1205597
   PubMed Web of Science ®Google Scholar
• Shaw RJ, Akufo-Tetteh EK, Risk JM, Field JK, Liloglou T. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing. Nucleic Acids Res 2006; 34:e78; PMID:16807314; http://dx.doi.org/10.1093/nar/gkl424
   PubMedGoogle Scholar
• Viet CT, Schmidt BL. Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients. Cancer Epidemiol Biomarkers Prev 2008; 17:3603-11; PMID:19064577; http://dx.doi.org/10.1158/1055-9965.EPI-08-0507
   PubMed Web of Science ®Google Scholar
• Viswanathan M, Tsuchida N, Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer 2003; 105:41-6; PMID:12672028; http://dx.doi.org/10.1002/ijc.11028
   PubMed Web of Science ®Google Scholar
• Carvalho AL, Jeronimo C, Kim MM, Henrique R, Zhang Z, Hoque MO, Chang S, Brait M, Nayak CS, Jiang WW, et al. Evaluation of promoter hypermethylation detection in body fluids as a Screening/Diagnosis tool for head and neck squamous cell carcinoma. Clinical Cancer Research 2008; 14:97-107; PMID:18172258; http://dx.doi.org/10.1158/1078-0432.CCR-07-0722
   PubMed Web of Science ®Google Scholar
• Mosch B, Reissenweber B, Neuber C, Pietzsch J. Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis. J Oncol 2010; 2010:135285; PMID:20224755
   PubMedGoogle Scholar
• Hu L, Sham JS, Xie D, Wen JM, Wang WS, Wang Y, Guan XY. Up-regulation of fibroblast growth factor 3 is associated with tumor metastasis and recurrence in human hepatocellular carcinoma. Cancer Lett 2007; 252:36-42; PMID:17215076; http://dx.doi.org/10.1016/j.canlet.2006.12.003
   PubMed Web of Science ®Google Scholar
• Ruscica M, Dozio E, Motta M, Magni P. Relevance of the neuropeptide Y system in the biology of cancer progression. Curr Top Med Chem 2007; 7:1682-91; PMID:17979777; http://dx.doi.org/10.2174/156802607782341019
   PubMed Web of Science ®Google Scholar
• Kitlinska J. Neuropeptide Y in neural crest-derived tumors: effect on growth and vascularization. Cancer Lett 2007; 245:293-302; PMID:16513255; http://dx.doi.org/10.1016/j.canlet.2006.01.010
   PubMed Web of Science ®Google Scholar
• Ju YT, Chang AC, She BR, Tsaur ML, Hwang HM, Chao CC, Cohen SN, Lin-Chao S. gas7: A gene expressed preferentially in growth-arrested fibroblasts and terminally differentiated Purkinje neurons affects neurite formation. Proc Natl Acad Sci U S A 1998; 95:11423-8; PMID:9736752; http://dx.doi.org/10.1073/pnas.95.19.11423
   PubMed Web of Science ®Google Scholar
• Ball DW. Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancer. Cancer Lett 2004; 204:159-69; PMID:15013215; http://dx.doi.org/10.1016/S0304-3835(03)00452-X
   PubMed Web of Science ®Google Scholar
• Chang JT, Lu YC, Chen YJ, Tseng CP, Chen YL, Fang CW, Cheng AJ. hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells. Br J Cancer 2006; 94:870-8; PMID:16508638; http://dx.doi.org/10.1038/sj.bjc.6603008
   PubMed Web of Science ®Google Scholar
• Sherwood NM, Krueckl SL, McRory JE. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 2000; 21:619-70; PMID:11133067
   PubMed Web of Science ®Google Scholar
• Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999; 31:273-300; PMID:10517533; http://dx.doi.org/10.1080/10715769900300851
   PubMed Web of Science ®Google Scholar
• Thirumoorthy N, Manisenthil Kumar KT, Shyam Sundar A, Panayappan L, Chatterjee M. Metallothionein: an overview. World J Gastroenterol 2007; 13:993-6; PMID:17373731; http://dx.doi.org/10.3748/wjg.v13.i7.993
   PubMed Web of Science ®Google Scholar
• Chand HS, Schmidt AE, Bajaj SP, Kisiel W. Structure-function analysis of the reactive site in the first Kunitz-type domain of human tissue factor pathway inhibitor-2. J Biol Chem 2004; 279:17500-7; PMID:14970225; http://dx.doi.org/10.1074/jbc.M400802200
   PubMed Web of Science ®Google Scholar
• Petersen LC, Sprecher CA, Foster DC, Blumberg H, Hamamoto T, Kisiel W. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 1996; 35:266-72; PMID:8555184; http://dx.doi.org/10.1021/bi951501d
   PubMed Web of Science ®Google Scholar
• Konduri SD, Tasiou A, Chandrasekar N, Rao JS. Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro. Int J Oncol 2001; 18:127-31; PMID:11115549
   PubMed Web of Science ®Google Scholar
• Lai YH, He RY, Chou JL, Chan MW, Li YF, Tai CK. Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma. Journal of translational medicine 2014; 12:237; PMID:25179542; http://dx.doi.org/10.1186/s12967-014-0237-7
   PubMed Web of Science ®Google Scholar
• Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY, Tung EK, Ching YP, Ng IO. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 2007; 45:1129-38; PMID:17464989; http://dx.doi.org/10.1002/hep.21578
   PubMed Web of Science ®Google Scholar
• Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18:4-25; PMID:9034784; http://dx.doi.org/10.1210/edrv.18.1.0287
   PubMed Web of Science ®Google Scholar
• Ferrara N, Bunting S. Vascular endothelial growth factor, a specific regulator of angiogenesis. Curr Opin Nephrol Hypertens 1996; 5:35-44; PMID:8834160; http://dx.doi.org/10.1097/00041552-199601000-00008
   PubMedGoogle Scholar
• Klagsbrun M, D'Amore PA. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 1996; 7:259-70; PMID:8971481; http://dx.doi.org/10.1016/S1359-6101(96)00027-5
   PubMedGoogle Scholar
• Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol 1999; 9:211-20; PMID:10343072; http://dx.doi.org/10.1006/scbi.1998.0091
   PubMed Web of Science ®Google Scholar
• Guan M, Xu C, Zhang F, Ye C. Aberrant methylation of EphA7 in human prostate cancer and its relation to clinicopathologic features. Int J Cancer 2009; 124:88-94; PMID:18821581; http://dx.doi.org/10.1002/ijc.23890
   PubMed Web of Science ®Google Scholar
• Wang J, Kataoka H, Suzuki M, Sato N, Nakamura R, Tao H, Maruyama K, Isogaki J, Kanaoka S, Ihara M, et al. Downregulation of EphA7 by hypermethylation in colorectal cancer. Oncogene 2005; 24:5637-47; PMID:16007213; http://dx.doi.org/10.1038/sj.onc.1208720
   PubMed Web of Science ®Google Scholar
• Peng DF, Razvi M, Chen H, Washington K, Roessner A, Schneider-Stock R, El-Rifai W. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut 2009; 58:5-15; PMID:18664505; http://dx.doi.org/10.1136/gut.2007.146290
   PubMed Web of Science ®Google Scholar
• Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, et al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res 2007; 13:7296-304; PMID:18094410; http://dx.doi.org/10.1158/1078-0432.CCR-07-0861
   PubMed Web of Science ®Google Scholar
• Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, Doucet D, Thomas NJ, Wang Y, Vollmer E, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006; 16:383-93; PMID:16449502; http://dx.doi.org/10.1101/gr.4410706
   PubMed Web of Science ®Google Scholar
• Gigek CO, Leal MF, Silva PN, Lisboa LC, Lima EM, Calcagno DQ, Assumpcao PP, Burbano RR, Smith Mde A. hTERT methylation and expression in gastric cancer. Biomarkers 2009; 14:630-6; PMID:20001710; http://dx.doi.org/10.3109/13547500903225912
   PubMed Web of Science ®Google Scholar
• Clement G, Braunschweig R, Pasquier N, Bosman FT, Benhattar J. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation. J Pathol 2006; 208:100-7; PMID:16278815; http://dx.doi.org/10.1002/path.1884
   PubMed Web of Science ®Google Scholar
• Jithesh PV, Risk JM, Schache AG, Dhanda J, Lane B, Liloglou T, Shaw RJ. The epigenetic landscape of oral squamous cell carcinoma. Br J Cancer 2013; 108:370-9; PMID:23287992; http://dx.doi.org/10.1038/bjc.2012.568
   PubMed Web of Science ®Google Scholar
• Nagata S, Hamada T, Yamada N, Yokoyama S, Kitamoto S, Kanmura Y, Nomura M, Kamikawa Y, Yonezawa S, Sugihara K. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma. Cancer 2012; 118:4298-308; PMID:22252571; http://dx.doi.org/10.1002/cncr.27417
   PubMed Web of Science ®Google Scholar
• Richards KL, Zhang B, Baggerly KA, Colella S, Lang JC, Schuller DE, Krahe R. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One 2009; 4:e4941; PMID:19293934; http://dx.doi.org/10.1371/journal.pone.0004941
   PubMed Web of Science ®Google Scholar
• Sartor MA, Dolinoy DC, Jones TR, Colacino JA, Prince ME, Carey TE, Rozek LS. Genome-wide methylation and expression differences in HPV(+) and HPV(−) squamous cell carcinoma cell lines are consistent with divergent mechanisms of carcinogenesis. Epigenetics 2011; 6:777-87; PMID:21613826; http://dx.doi.org/10.4161/epi.6.6.16216
   PubMed Web of Science ®Google Scholar
• Shaw R, Robinson M. The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer. Br J Oral Maxillofac Surg 2011; 49:423-9; PMID:20727631; http://dx.doi.org/10.1016/j.bjoms.2010.06.023
   PubMed Web of Science ®Google Scholar
• Chang KC, Su IJ, Tsai ST, Shieh DB, Jin YT. Pathological features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association. Oncology 2002; 63:362-9; PMID:12417791; http://dx.doi.org/10.1159/000066227
   PubMed Web of Science ®Google Scholar
• Righini CA, de Fraipont F, Timsit JF, Faure C, Brambilla E, Reyt E, Favrot MC. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 2007; 13:1179-85; PMID:17317827; http://dx.doi.org/10.1158/1078-0432.CCR-06-2027
   PubMed Web of Science ®Google Scholar